WO2002060878A1 - Benzimidazolidinone derivatives - Google Patents
Benzimidazolidinone derivatives Download PDFInfo
- Publication number
- WO2002060878A1 WO2002060878A1 PCT/JP2002/000692 JP0200692W WO02060878A1 WO 2002060878 A1 WO2002060878 A1 WO 2002060878A1 JP 0200692 W JP0200692 W JP 0200692W WO 02060878 A1 WO02060878 A1 WO 02060878A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- optionally substituted
- substituted alkyl
- hydrogen
- general formula
- benzimidazolidinone derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/26—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
- A61P5/46—Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of glucocorticosteroids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Physical Education & Sports Medicine (AREA)
- Diabetes (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Child & Adolescent Psychology (AREA)
- Dermatology (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2002561028A JPWO2002060878A1 (ja) | 2001-01-30 | 2002-01-30 | ベンズイミダゾリジノン誘導体 |
EP02710385A EP1364945A4 (en) | 2001-01-30 | 2002-01-30 | BENZIMIDAZOLIDINONE DERIVATIVES |
US10/470,813 US6939887B2 (en) | 2001-01-30 | 2002-01-30 | Benzimidazolidinone derivatives |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2001022352 | 2001-01-30 | ||
JP2001-22352 | 2001-01-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2002060878A1 true WO2002060878A1 (en) | 2002-08-08 |
Family
ID=18887782
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2002/000692 WO2002060878A1 (en) | 2001-01-30 | 2002-01-30 | Benzimidazolidinone derivatives |
Country Status (4)
Country | Link |
---|---|
US (1) | US6939887B2 (ja) |
EP (1) | EP1364945A4 (ja) |
JP (1) | JPWO2002060878A1 (ja) |
WO (1) | WO2002060878A1 (ja) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005035498A1 (ja) * | 2003-10-08 | 2005-04-21 | Dainippon Sumitomo Pharma Co., Ltd. | 含窒素二環性化合物の摂食調節剤としての用途 |
WO2011116671A1 (zh) | 2010-03-22 | 2011-09-29 | 中国中化股份有限公司 | 一种取代二苯胺类化合物及其制备与应用 |
WO2013135147A1 (zh) | 2012-03-14 | 2013-09-19 | 中国中化股份有限公司 | 取代二苯胺类化合物作为制备抗肿瘤药物的应用 |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2003233244B2 (en) * | 2002-06-07 | 2010-05-20 | Cortical Pty Ltd | Therapeutic molecules and methods-1 |
WO2007032371A1 (ja) | 2005-09-14 | 2007-03-22 | Dainippon Sumitomo Pharma Co., Ltd. | 摂食調節剤としてのオキシインドール誘導体 |
US20070219193A1 (en) * | 2006-03-17 | 2007-09-20 | Kalypsys, Inc | Alkylamine-substituted bicyclic aryl compounds useful as modulators of ppar |
FR2941946B1 (fr) * | 2009-02-12 | 2011-03-25 | Sanofi Aventis | Derives de 3-benzofuranyl-indol-2-one-3-acetamidopiperazines substitues, leur preparation et leur application en therapeutique |
FR2941947B1 (fr) * | 2009-02-12 | 2011-03-25 | Sanofi Aventis | Derives de 3-benzofuranyl-indol-2-one subtitues en 3, leur preparation et leur application en therapeutique |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2714437A1 (de) * | 1976-04-02 | 1977-10-20 | Janssen Pharmaceutica Nv | Piperazin- und piperidinderivate, verfahren zu ihrer herstellung und arzneipraeparate |
WO2000010975A1 (en) * | 1998-08-20 | 2000-03-02 | Sumitomo Pharmaceuticals Co., Ltd. | Oxindole derivatives as growth hormone releasers |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4200641A (en) * | 1976-12-21 | 1980-04-29 | Janssen Pharmaceutica, N.V. | 1-[(Heterocyclyl)-alkyl]-4-diarylmethoxy piperidine derivatives |
FR2722190B1 (fr) * | 1994-07-05 | 1996-10-04 | Sanofi Sa | Derives de 1-benzyl-1,3-dihydro-2h-benzimidazol-2-one, leur preparation, les compositions pharmaceutique en contenant |
GB9613423D0 (en) * | 1996-06-26 | 1996-08-28 | Lilly Industries Ltd | Pharmaceutical compounds |
EP1196391A1 (en) * | 1999-07-21 | 2002-04-17 | Fujisawa Pharmaceutical Co., Ltd. | Benzimidazolone derivatives and their use as phosphodiesterase inhibitors |
-
2002
- 2002-01-30 JP JP2002561028A patent/JPWO2002060878A1/ja active Pending
- 2002-01-30 WO PCT/JP2002/000692 patent/WO2002060878A1/ja not_active Application Discontinuation
- 2002-01-30 US US10/470,813 patent/US6939887B2/en not_active Expired - Fee Related
- 2002-01-30 EP EP02710385A patent/EP1364945A4/en not_active Withdrawn
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2714437A1 (de) * | 1976-04-02 | 1977-10-20 | Janssen Pharmaceutica Nv | Piperazin- und piperidinderivate, verfahren zu ihrer herstellung und arzneipraeparate |
WO2000010975A1 (en) * | 1998-08-20 | 2000-03-02 | Sumitomo Pharmaceuticals Co., Ltd. | Oxindole derivatives as growth hormone releasers |
Non-Patent Citations (1)
Title |
---|
See also references of EP1364945A4 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005035498A1 (ja) * | 2003-10-08 | 2005-04-21 | Dainippon Sumitomo Pharma Co., Ltd. | 含窒素二環性化合物の摂食調節剤としての用途 |
WO2011116671A1 (zh) | 2010-03-22 | 2011-09-29 | 中国中化股份有限公司 | 一种取代二苯胺类化合物及其制备与应用 |
WO2013135147A1 (zh) | 2012-03-14 | 2013-09-19 | 中国中化股份有限公司 | 取代二苯胺类化合物作为制备抗肿瘤药物的应用 |
Also Published As
Publication number | Publication date |
---|---|
JPWO2002060878A1 (ja) | 2004-06-03 |
US20040142850A1 (en) | 2004-07-22 |
EP1364945A4 (en) | 2005-08-31 |
US6939887B2 (en) | 2005-09-06 |
EP1364945A1 (en) | 2003-11-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2001072728A3 (en) | Novel piperazine derivatives | |
WO2004011453A3 (en) | Method for preparing 3-halo-4,5-dihydro-1h-pyrazoles | |
EP1036794A4 (en) | 2-ARYL-8-OXODIHYDROPURIN DERIVATIVES, THEIR PRODUCTION, THEIR USE AS MEDICINE COMPONENTS AND THEIR INTERMEDIATES | |
CA2445306A1 (en) | Process for preparing 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivatives | |
EP1674452A4 (en) | NOVEL 4-PHENYLAMINO-BENZALDOXIME DERIVATIVE AND ITS USE AS MEK INHIBITOR | |
WO2003034997A3 (en) | Modulators of phosphoinositide 3-kinase | |
MXPA02003977A (es) | Inhibidores de adhesion de celula mediada por al°2. | |
CA2372270A1 (en) | C-2 modified erythromycin derivatives | |
WO2002102787A3 (en) | Novel sulfonic acid derivatives | |
EP1279665A3 (en) | A process for the preparation of perindopril, its analogous compounds and salts thereof using 2,5-dioxo-oxazolidine intermediate compounds | |
AU2722095A (en) | Novel pyrrolocarbazoles | |
WO2002032901A3 (en) | Bridged piperazine derivatives | |
WO2002060878A1 (en) | Benzimidazolidinone derivatives | |
BG104447A (en) | Biphenylamidine derivatives | |
WO1997031016A3 (en) | New inhibitors of sh2-mediated processes | |
ZA9810320B (en) | Process for the preparation of 1,4-dihydropyridines and novel compounds of use for such purpose. | |
BG107050A (en) | Method for the preparation of citalopram | |
WO2000046210A3 (en) | New process for preparing pesticidal intermediates | |
EP1043311A4 (en) | BIPHENYLAMIDINE DERIVATIVES | |
EP1612211A4 (en) | NEW CARBAPENEM COMPOUNDS | |
EP1310490A4 (en) | GPR14 ANTAGONIST | |
CA2419764A1 (en) | Process for preparing a substituted imidazopyridine compound | |
EP1227081A4 (en) | PROCESS FOR THE PREPARATION OF OXYMINOALKANOIC ACID DERIVATIVES | |
EP1118615A4 (en) | PYRIDOPYRAZINE DERIVATIVES SALTS AND CRYSTALS THEREOF | |
WO2002017954A1 (fr) | Medicaments contre la maladie de parkinson |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2002561028 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10470813 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2002710385 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2002710385 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2002710385 Country of ref document: EP |